HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.

By FierceBiotech · Apr 17, 2026 · via FierceBiotech
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Image: FierceBiotech

This is an aggregated industry headline. Read the full story at FierceBiotech →

Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
Rising Stars: WPP's Meghan O'Hora on the 'complex puzzle' of oncology drug marketing
The WeekFiercePharma ↗
Rising Stars: WPP's Meghan O'Hora on the 'complex puzzle' of oncology drug marketing
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
Jun 3, 2026
New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
The WeekFierceBiotech ↗
New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
Jun 3, 2026
Cingulate’s FDA Rejection Centers on Manufacturing, Not Safety
The WeekBriefing
Cingulate’s FDA Rejection Centers on Manufacturing, Not Safety
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…
Jun 3, 2026